Prognostic impact of caspase‐8 mutation in oral cavity squamous cell carcinoma
Oral Diseases · 2025-03 · 31 (3) · 769-781
DOI: 10.1111/odi.15124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 17.09.2024. Verfasst von Hsueh-Ju Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Caspase 8, Mouth Neoplasms, Mutation, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Chung Shan Medical University Hospital.
Abstract (Originalsprache)
Objective
Identifying the drive genes and inhibiting their significant signals were persistently the main concepts in cancer treatment. However, for oral cavity squamous cell carcinoma (OCSCC), the most influential genes for overall survival (OS) remain unclear.
Methods
A total of 120 OCSCC patients with corresponding pathologic specimens were collected in Taiwan. Whole‐exome sequencing was done and the prognostic impact of each gene was analyzed. TCGA database was used to validate.
Results
The incidences of caspase‐8 mutation were 22.1% and 10.9% in the Taiwan and TCGA cohort, respectively. In the Taiwan cohort, caspase‐8 mutation was the most significant independent for OS with an adjusted hazard ratio (HR) ([95% CI]: 3.83 [1.84–7.99]). It was validated by the TCGA database (HR [95% CI]: 1.51 [1.00–2.29]). The 5‐year OSs of the patients with or without caspase‐8 mutation were 38.1% vs. 75.3% ( p < 0.001) (HR [95% CI]: 3.264 [1.645–6.438]) in the Taiwan cohort, and 26.1% vs. 49.0% ( p = 0.048) (1.513 [1.001–2.288]) in the TCGA cohorts, respectively. Caspase‐8 mutation was also individually associated with poor prognosis for TNM stage I/II/III/IV, respectively. CASP8 R127* and R494*, defined as pathogenic mutations in ClinVar, were presented in both cohorts.
Conclusions
Caspase‐8 mutation was the most significant genetic alteration impacting prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan.
- Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
ORCID-Profile: Hsueh-Ju Lu, Shun-Fa Yang
Förderung
- Chung Shan Medical University Hospital
Zitieren
APA
Lu, H. J., Su, C. W., Su, S. C., Chang, L. C., Wu, M. F., Lin, C. W., & Yang, S. F. (2025). Prognostic impact of caspase‐8 mutation in oral cavity squamous cell carcinoma. Oral Diseases, 31(3), 769-781. https://doi.org/10.1111/odi.15124
Vancouver
Lu HJ, Su CW, Su SC, Chang LC, Wu MF, Lin CW, et al. Prognostic impact of caspase‐8 mutation in oral cavity squamous cell carcinoma. Oral Diseases. 2025;31(3):769-781. doi:10.1111/odi.15124
BibTeX
@article{Lu2025,
author = {Lu, Hsueh-Ju and Su, Chun-Wen and Su, Shih-Chi and Chang, Lun-Ching and Wu, Ming-Fang and Lin, Chiao-Wen and Yang, Shun-Fa},
title = {Prognostic impact of caspase‐8 mutation in oral cavity squamous cell carcinoma},
journal = {Oral Diseases},
year = {2025},
volume = {31},
number = {3},
pages = {769--781},
doi = {10.1111/odi.15124}
}
EUVIMED